Merck’s $10.8B Prometheus buyout, GSK’s $2B Bellus takeover fuel M&A buzz; CAR-T data leak; Best of #AACR23; and more
Welcome back to Endpoints Weekly, your review of the week’s top biopharma headlines. Want this in your inbox every Saturday morning? Current Endpoints readers …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.